Early findings from an ongoing study report that a group of 20 firefighters tested after the Palisades and Eaton fires had ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
ZME Science on MSN7d
A New Study Reveals AI Is Hiding Its True Intent and It’s Getting Better At ItAt first glance, this seems like a win for transparency. If an AI explains itself, we can understand its motives, catch ...
A leading global democracy research institute says democratic “backsliding” must be turned around quickly—warning that after ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer. Initiation of trial sites underway for ground ...
Women and girls’ lives are being lost due to the abrupt and sweeping cancellation of U.S. assistance approved by Congress.
The biotech is exploring opportunities for a reverse merger or other business combinations. CFO and now interim CEO Anup ...
Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback